exocad releases PartialCAD for Partial Framework Design

Food and Healthcare Press Releases Wednesday April 11, 2018 14:50
DARMSTADT, Germany--11 Apr--PRNewswire/InfoQuest
exocad recently announced the commercial availability of its Partial Framework Design module.

exocad's PartialCAD provides unparalleled flexibility and design freedom thanks to its unique voxel-based technology. Tillmann Steinbrecher, CEO of exocad, says: "Our goal is that anything that can be made in wax, can also be designed with exocad. With this new module, even the most demanding experts in Removable Partial Dentures will find their design needs met."

Mr. Steinbrecher also points out that "the traditional process of creating partial frameworks is fully analog and both resource intensive and time consuming."   He says that "The PartialCAD module enables efficient production with 3d printers or milling machines, thus saving time and increasing productivity."

Partial Frameworks can be combined with crown and bridge designs, or other indications available in the exocad DentalCAD platform - e.g. for secondary structures on telescopic crowns, attachments, advanced implant cases, and more.

About exocad GmbH

exocad GmbH (exocad.com) is a dynamic and innovative software company committed to expanding the possibilities of digital dentistry and providing OEMs (Original Equipment Manufacturers) with flexible, reliable, and easy-to-use CAD/CAM software for dental labs and dental practices. exocad software has been chosen by leading OEMs worldwide for integration into their dental CAD/CAM offerings, and thousands of exocad DentalCAD licenses are sold each year. For more information and a list of exocad reseller partners, please visit exocad.com.

Photo - https://mma.prnewswire.com/media/665021/partial_framework_02.jpg

Latest Press Release

Boehringer Ingelheim has a very successful 2017 financial year

- Sharp increase in net sales to nearly 18.1 billion euros (+15.7 per cent in currency-adjusted terms; +13.9 per cent in euro terms) - Operating income rises significantly to around 3.5 billion euros - Return on net sales of 19.3 per cent - Strengthened...

Merck Receives Patent for CRISPR Technology in China

- Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells - Company to license CRISPR-related patents to interested parties, supports genome-editing research under ethical and legal standards -...

Cell and Gene Therapy Catapult Opens Manufacturing Centre to Accelerate Growth of the Industry in the UK

- Centre will 'bridge the gap' between scientific research and commercialisation of the medicines of the future - Over GBP60 million of Industrial Strategy investment is being used to develop the new centre Today,the Cell and Gene Therapy Catapult's...

Creation of Inceptua Clinical Trial Services Marks New Era for the Company

Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including Clinical Trial Services, Medicines...

FDI White Paper and Practical Guide Address the Global Burden of Periodontal Disease

FDI World Dental Federation published two resources - a white paper and a practical guide - as part of its Global Periodontal Health Project (GPHP), which aims to bring attention to periodontal health as a priority area for policy worldwide. (Logo:...

Related Topics